Riskpilot← Back to searchSign inGet full accessGenevia Technologies Oy
OYActiveY-tunnus 2417971-1Hämeenkatu 14-C33Research and experimental development on natural sciences and engineering · NACE 7210Est. 2011— employeeswww.geneviatechnologies.com
Revenue 2025
EUR 0
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2025
EUR 0
-100% vs 2024
| Revenue | EUR 0 | — |
| EBITDA | EUR 0 | — |
| Net profit | EUR 0 | -100% |
| Total assets | EUR 0 | -100% |
| Equity | EUR 0 | -100% |
| Employees | — | — |
Legal name
Genevia Technologies Oy
Y-tunnus number
2417971-1
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
8. heinäkuuta 2011
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on bioalan asiantuntijapalvelut ja muu laillinen liiketoiminta.
Address
Hämeenkatu 14-C33
Phone
+358407477672
Email
info@geneviatechnologies.com
Website
www.geneviatechnologies.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 748 | 859 | 1 422 | 2 047 | 0 |
| Staff expenses | −748 | −644 | −661 | −842 | −0 |
| EBITDA | 9 | 72 | 314 | 525 | 0 |
| Depreciation & amort. | −4 | −5 | −10 | −14 | −0 |
| EBIT | 5 | 67 | 304 | 511 | 0 |
| Net financials | −1 | −1 | −0 | 1 | 0 |
| Profit before tax | 4 | 67 | 304 | 512 | 0 |
| Tax | 1 | 14 | 61 | 103 | −0 |
| Net profit | 3 | 53 | 243 | 409 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 645 | 515 | 1 026 | 1 691 | 0 |
| Equity | 247 | 299 | 541 | 947 | 0 |
| Long-term debt | 18 | — | 0 | 0 | 0 |
| Short-term debt | 381 | 215 | 484 | 745 | 0 |
| Total debt | 398 | 215 | 484 | 745 | 0 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212025
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JA Audit | Audit | 2026 |
AK Chief Executive Officer | Chief Executive Officer | 2012 |
SK Deputy auditor | Deputy auditor | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2014 | |
| Board of Directors | 2014 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Genevia Technologies Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jari Antero Kekki | Audit | 0 companies |
| Antti Kari Petteri Ylipää | Chief Executive Officer | 0 companies |
| Susanna Katja Maaria Mäkiranta | Deputy auditor | 0 companies |
| Klaus Erik Breitholtz | Board of Directors | 0 companies |
| Matti Pekka Mikael Nykter | Board of Directors | 0 companies |